These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

555 related articles for article (PubMed ID: 32179695)

  • 1. Role of staging surgery and adjuvant chemotherapy in adult patients with apparent stage I pure immature ovarian teratoma after fertility-sparing surgery.
    Wang D; Zhu S; Jia C; Cao D; Wu M; Shen K; Yang J; Xiang Y
    Int J Gynecol Cancer; 2020 May; 30(5):664-669. PubMed ID: 32179695
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Is adjuvant chemotherapy indicated in stage I pure immature ovarian teratoma (IT)? A multicentre Italian trial in ovarian cancer (MITO-9).
    Mangili G; Scarfone G; Gadducci A; Sigismondi C; Ferrandina G; Scibilia G; Viganò R; Tateo S; Villa A; Lorusso D
    Gynecol Oncol; 2010 Oct; 119(1):48-52. PubMed ID: 20599258
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immature teratoma of ovary--outcome following primary and secondary surgery: study of a single institution cohort.
    Reddihalli PV; Subbian A; Umadevi K; Rathod PS; Krishnappa S; Nanaiah SP; Bafna UD
    Eur J Obstet Gynecol Reprod Biol; 2015 Sep; 192():17-21. PubMed ID: 26142911
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pure Immature Teratoma of the Ovary in Adults: Thirty-Year Experience of a Single Tertiary Care Center.
    Alwazzan AB; Popowich S; Dean E; Robinson C; Lotocki R; Altman AD
    Int J Gynecol Cancer; 2015 Nov; 25(9):1616-22. PubMed ID: 26332392
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oncological and Reproductive Outcomes of Cystectomy Compared with Unilateral Salpingo-Oophorectomy as Fertility-Sparing Surgery in Patients with Apparent Early Stage Pure Immature Ovarian Teratomas.
    Wang D; Zhu S; Jia C; Cao D; Yang J; Xiang Y
    Ann Surg Oncol; 2021 Oct; 28(11):6684-6693. PubMed ID: 33772392
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fertility-Sparing Surgery Should Be the Standard Treatment in Patients with Malignant Ovarian Germ Cell Tumors.
    Turkmen O; Karalok A; Basaran D; Kimyon GC; Tasci T; Ureyen I; Tulunay G; Turan T
    J Adolesc Young Adult Oncol; 2017 Jun; 6(2):270-276. PubMed ID: 28085535
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic factors for pure ovarian immature teratoma and the role of adjuvant chemotherapy in stage I diseases.
    Li S; Zhang X; Zhang T; Yin M; Cao D; Xiang Y; Yang J
    Ann Med; 2023; 55(2):2273984. PubMed ID: 37909181
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Prognostic comparison of active surveillance and adjuvant chemotherapy in the treatment of patients with stage Ⅰ ovarian immature teratoma after fertility-sparing surgery].
    Zhang XY; Yang J; Xiang Y; Wu M; Pan LY; Yang JX
    Zhonghua Fu Chan Ke Za Zhi; 2023 Nov; 58(11):838-845. PubMed ID: 37981770
    [No Abstract]   [Full Text] [Related]  

  • 9. Pediatric ovarian immature teratoma: Histological grading and clinical characteristics.
    Shinkai T; Masumoto K; Chiba F; Shirane K; Tanaka Y; Aiyoshi T; Sasaki T; Ono K; Gotoh C; Urita Y; Takayasu H; Suzuki R; Sakashita S
    J Pediatr Surg; 2020 Apr; 55(4):707-710. PubMed ID: 31130350
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Is adjuvant chemotherapy indicated in ovarian immature teratomas? A combined data analysis from the Malignant Germ Cell Tumor International Collaborative.
    Pashankar F; Hale JP; Dang H; Krailo M; Brady WE; Rodriguez-Galindo C; Nicholson JC; Murray MJ; Bilmire DF; Stoneham S; Arul GS; Olson TA; Stark D; Shaikh F; Amatruda JF; Covens A; Gershenson DM; Frazier AL
    Cancer; 2016 Jan; 122(2):230-7. PubMed ID: 26485622
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Can we replace adjuvant chemotherapy with surveillance for stage IA-C immature ovarian teratomas of any grade? an international multicenter analysis.
    Bergamini A; Sarwar N; Ferrandina G; Scarfone G; Short D; Aguiar X; Camnasio C; Kaur B; Savage PM; Cormio G; Lim A; Pignata S; Mangili G; Seckl MJ
    Eur J Cancer; 2020 Sep; 137():136-143. PubMed ID: 32763784
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Outcomes of Surgery Alone and Surveillance Strategy in Young Women With Stage I Malignant Ovarian Germ Cell Tumors.
    Park JY; Kim DY; Suh DS; Kim JH; Kim YM; Kim YT; Nam JH
    Int J Gynecol Cancer; 2016 Jun; 26(5):859-64. PubMed ID: 27101582
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ovarian cystectomy in the treatment of apparent early-stage immature teratoma.
    Zhao T; Liu Y; Wang X; Zhang H; Lu Y
    J Int Med Res; 2017 Apr; 45(2):771-780. PubMed ID: 28415950
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fertility-sparing surgery for patients with malignant ovarian germ cell tumors: 10 years of clinical experience from a tertiary referral center.
    Mikuš M; Benco N; Matak L; Planinić P; Ćorić M; Lovrić H; Radošević V; Puževski T; Bajt M; Vujić G
    Arch Gynecol Obstet; 2020 May; 301(5):1227-1233. PubMed ID: 32253553
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of staging and adjuvant chemotherapy in stage I malignant ovarian germ cell tumors (MOGTs): the MITO-9 study.
    Mangili G; Sigismondi C; Lorusso D; Cormio G; Candiani M; Scarfone G; Mascilini F; Gadducci A; Mosconi AM; Scollo P; Cassani C; Pignata S; Ferrandina G
    Ann Oncol; 2017 Feb; 28(2):333-338. PubMed ID: 27803008
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Management strategy for children with ovarian immature teratoma: results from a tertiary pediatric oncology center.
    Ahmed G; Khalil SA; Elshafiey M; Abdelfattah N; Eid M; Zakaria AS; Elwakeel M; Elgendy A
    World J Surg Oncol; 2024 Jul; 22(1):176. PubMed ID: 38965563
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Surgical resection alone is effective treatment for ovarian immature teratoma in children and adolescents: a report of the pediatric oncology group and the children's cancer group.
    Cushing B; Giller R; Ablin A; Cohen L; Cullen J; Hawkins E; Heifetz SA; Krailo M; Lauer SJ; Marina N; Rao PV; Rescorla F; Vinocur CD; Weetman RM; Castleberry RP
    Am J Obstet Gynecol; 1999 Aug; 181(2):353-8. PubMed ID: 10454682
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Residual tumor after the salvage surgery is the major risk factors for primary treatment failure in malignant ovarian germ cell tumors: a retrospective study of single institution.
    Lee CW; Song MJ; Park ST; Ki EY; Lee SJ; Lee KH; Ryu KS; Park JS; Hur SY
    World J Surg Oncol; 2011 Oct; 9():123. PubMed ID: 21988930
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Characteristics of rare ovarian tumors--possibilities of organ preservation].
    Grischke EM; Wallwiener D; Bastert G
    Zentralbl Gynakol; 1996; 118(6):322-5. PubMed ID: 8768007
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Prognostic factors analysis in patients with ovarian malignant germ cell tumor treated with fertility-preserving surgery].
    Yang ZJ; Wei RJ; Li L
    Zhonghua Fu Chan Ke Za Zhi; 2012 Dec; 47(12):898-904. PubMed ID: 23324188
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.